Skip to content

Geheugenfunctie en doorbloeding van de hersenen na recente pre-eclampsie.

Cognitive function in relation to cerebral blood flow regulation after preeclampsia.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON28661
Enrollment
30
Registered
2008-12-17
Start date
2009-01-15
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cognition cerebral blood flow regulation preeclampsia pulse wave velocity cognitie cerebrale bloedstroom regulatie preeclampsie polsgolfsnelheid

Interventions

No interventions tested, but correlation between parameters (cerebral blood flow regulation and cognition) in a single patient group (former preeclamptics). Cerebral blood flow is measured non-invasi

Sponsors

University Hospital Maastricht
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Women who have been diagnosed with severe (clinical admission indispensable) early ( 18 years; 3. Informed consent of the patient before participation into the study.

Exclusion criteria

Exclusion criteria: 1. Neurological or cerebrovascular disorders in case history; 2. Kidney function disorder; 3. Use of statines; 4. Psychiatric case history or state (As I and II issues); 5. Use of anti-depression medicine; 6. Abuse of alcohol and/or drugs; 7. Smoking or refrained from smoking less than 2 years; 8. Diabetes.

Design outcomes

Primary

MeasureTime frame
Correlation between degree of disturbance of the cerebrovascular control system and cognitive function in former preeclamptic patients.

Secondary

MeasureTime frame
Correlation between presence of cognitive complaints and cognitive function (NPO-scores). Correlation between presence of cognitive complaints and cerebrovascular control parameters.

Contacts

Public ContactE. Martens

University Hospital Maastricht Dept. Clinical Neurophysiology P. Debyelaan 25

esther.martens@mumc.nl+31 (0)43-387 5270

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)